SANGSTAT'S PRA-STAT PRE-ORGAN TRANSPLANT MONITORING PRODUCT POISED FOR 1994 EUROPEAN DEBUT; IPO RAISES $11 MIL. TO SUPPORT R&D, CAPITAL EXPENSES
This article was originally published in The Gray Sheet
Executive Summary
SangStat Medical Corporation is setting its sights on Europe this year to unveil its Pra-Stat pre-transplant monitoring product for improved organ donor/recipient compatibility.